nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA5—lung cancer	0.0173	0.0906	CbGpPWpGaD
Carbidopa—DDC—Nicotine Activity on Dopaminergic Neurons—CHRNA3—lung cancer	0.0141	0.0739	CbGpPWpGaD
Carbidopa—DDC—Dopamine metabolism—NQO1—lung cancer	0.0139	0.0729	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—HSD17B10—lung cancer	0.0131	0.0687	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—UCHL1—lung cancer	0.013	0.068	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—SOX2—lung cancer	0.00986	0.0516	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00614	0.0321	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP2E1—lung cancer	0.00512	0.0268	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.00425	0.0223	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CAT—lung cancer	0.00411	0.0215	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—CKB—lung cancer	0.00396	0.0207	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—KMT2A—lung cancer	0.00375	0.0196	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.00374	0.0196	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00372	0.0195	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—CYP1A1—lung cancer	0.00368	0.0193	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TOP1—lung cancer	0.00343	0.0179	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—NKX2-1—lung cancer	0.00334	0.0175	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.00284	0.0148	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—SOX2—lung cancer	0.00264	0.0138	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.00255	0.0134	CbGpPWpGaD
Carbidopa—DDC—Dopaminergic Neurogenesis—STAT3—lung cancer	0.0024	0.0126	CbGpPWpGaD
Carbidopa—DDC—Parkinsons Disease Pathway—CASP3—lung cancer	0.00237	0.0124	CbGpPWpGaD
Carbidopa—DDC—Tryptophan metabolism—MDM2—lung cancer	0.00227	0.0119	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—TF—lung cancer	0.00224	0.0117	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—AHR—lung cancer	0.00221	0.0116	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—ADCY1—lung cancer	0.00197	0.0103	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—GCLC—lung cancer	0.00195	0.0102	CbGpPWpGaD
Carbidopa—DDC—Amino acid and derivative metabolism—NQO1—lung cancer	0.00164	0.0086	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—AVP—lung cancer	0.00155	0.00814	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HES1—lung cancer	0.00147	0.00769	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL10—lung cancer	0.00146	0.00765	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—AVP—lung cancer	0.00127	0.00664	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.00123	0.00645	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—TYMS—lung cancer	0.00121	0.00632	CbGpPWpGaD
Carbidopa—DDC—Metabolism—COL4A3BP—lung cancer	0.00113	0.0059	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AZIN2—lung cancer	0.00113	0.0059	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6R—lung cancer	0.00101	0.00527	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.00101	0.00527	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ATP5H—lung cancer	0.000958	0.00502	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PLBD1—lung cancer	0.000854	0.00447	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000799	0.00418	CbGpPWpGaD
Carbidopa—DDC—Metabolism—HSD17B10—lung cancer	0.000781	0.00409	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000765	0.004	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—JUN—lung cancer	0.000743	0.00389	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CKB—lung cancer	0.000726	0.0038	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—EP300—lung cancer	0.000685	0.00359	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTM2—lung cancer	0.000683	0.00357	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CNDP2—lung cancer	0.000683	0.00357	CbGpPWpGaD
Carbidopa—DDC—Metabolism—MTMR3—lung cancer	0.000664	0.00348	CbGpPWpGaD
Carbidopa—DDC—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000649	0.0034	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PGAM1—lung cancer	0.000647	0.00339	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP2A7—lung cancer	0.000618	0.00323	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—JUN—lung cancer	0.000607	0.00317	CbGpPWpGaD
Carbidopa—DDC—Metabolism—SDC4—lung cancer	0.000604	0.00316	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—PTEN—lung cancer	0.000587	0.00307	CbGpPWpGaD
Carbidopa—DDC—Circadian rythm related genes—EP300—lung cancer	0.00056	0.00293	CbGpPWpGaD
Carbidopa—DDC—Metabolism—RRM1—lung cancer	0.00055	0.00288	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA3—lung cancer	0.00055	0.00288	CbGpPWpGaD
Carbidopa—DDC—Metabolism—B4GALT5—lung cancer	0.000518	0.00271	CbGpPWpGaD
Carbidopa—DDC—Metabolism—GSTA4—lung cancer	0.000503	0.00264	CbGpPWpGaD
Carbidopa—Hyperhidrosis—Paclitaxel—lung cancer	0.000491	0.000607	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTA2—lung cancer	0.000491	0.00257	CbGpPWpGaD
Carbidopa—Nasopharyngitis—Doxorubicin—lung cancer	0.000489	0.000604	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Cisplatin—lung cancer	0.000488	0.000604	CcSEcCtD
Carbidopa—Anaemia—Docetaxel—lung cancer	0.000488	0.000603	CcSEcCtD
Carbidopa—Depression—Methotrexate—lung cancer	0.000485	0.0006	CcSEcCtD
Carbidopa—Anorexia—Paclitaxel—lung cancer	0.000484	0.000599	CcSEcCtD
Carbidopa—Hypotension—Etoposide—lung cancer	0.000484	0.000599	CcSEcCtD
Carbidopa—Gastritis—Doxorubicin—lung cancer	0.000484	0.000598	CcSEcCtD
Carbidopa—Pain—Cisplatin—lung cancer	0.000484	0.000598	CcSEcCtD
Carbidopa—Vomiting—Vinorelbine—lung cancer	0.00048	0.000594	CcSEcCtD
Carbidopa—Body temperature increased—Gemcitabine—lung cancer	0.00048	0.000593	CcSEcCtD
Carbidopa—Rash—Vinorelbine—lung cancer	0.000476	0.000589	CcSEcCtD
Carbidopa—Dermatitis—Vinorelbine—lung cancer	0.000476	0.000588	CcSEcCtD
Carbidopa—Hypotension—Paclitaxel—lung cancer	0.000475	0.000587	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTA1—lung cancer	0.000473	0.00248	CbGpPWpGaD
Carbidopa—Headache—Vinorelbine—lung cancer	0.000473	0.000585	CcSEcCtD
Carbidopa—Syncope—Docetaxel—lung cancer	0.000473	0.000585	CcSEcCtD
Carbidopa—Dysphagia—Doxorubicin—lung cancer	0.000473	0.000584	CcSEcCtD
Carbidopa—Leukopenia—Docetaxel—lung cancer	0.000472	0.000584	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCC3—lung cancer	0.000468	0.00245	CbGpPWpGaD
Carbidopa—Palpitations—Docetaxel—lung cancer	0.000466	0.000576	CcSEcCtD
Carbidopa—Feeling abnormal—Cisplatin—lung cancer	0.000466	0.000576	CcSEcCtD
Carbidopa—Paraesthesia—Etoposide—lung cancer	0.000465	0.000575	CcSEcCtD
Carbidopa—Loss of consciousness—Docetaxel—lung cancer	0.000464	0.000573	CcSEcCtD
Carbidopa—Dyspnoea—Etoposide—lung cancer	0.000462	0.000571	CcSEcCtD
Carbidopa—Somnolence—Etoposide—lung cancer	0.000461	0.000569	CcSEcCtD
Carbidopa—Cough—Docetaxel—lung cancer	0.00046	0.000569	CcSEcCtD
Carbidopa—Insomnia—Paclitaxel—lung cancer	0.000459	0.000568	CcSEcCtD
Carbidopa—Hypersensitivity—Irinotecan—lung cancer	0.000459	0.000567	CcSEcCtD
Carbidopa—Convulsion—Docetaxel—lung cancer	0.000457	0.000565	CcSEcCtD
Carbidopa—Paraesthesia—Paclitaxel—lung cancer	0.000456	0.000564	CcSEcCtD
Carbidopa—Hypertension—Docetaxel—lung cancer	0.000456	0.000563	CcSEcCtD
Carbidopa—Agranulocytosis—Methotrexate—lung cancer	0.000454	0.000561	CcSEcCtD
Carbidopa—DDC—Metabolism—AKR1C1—lung cancer	0.000453	0.00237	CbGpPWpGaD
Carbidopa—Dyspnoea—Paclitaxel—lung cancer	0.000453	0.00056	CcSEcCtD
Carbidopa—Somnolence—Paclitaxel—lung cancer	0.000452	0.000558	CcSEcCtD
Carbidopa—Decreased appetite—Etoposide—lung cancer	0.00045	0.000557	CcSEcCtD
Carbidopa—Chest pain—Docetaxel—lung cancer	0.000449	0.000555	CcSEcCtD
Carbidopa—DDC—SIDS Susceptibility Pathways—IL6—lung cancer	0.000449	0.00235	CbGpPWpGaD
Carbidopa—Nausea—Vinorelbine—lung cancer	0.000449	0.000555	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Etoposide—lung cancer	0.000447	0.000553	CcSEcCtD
Carbidopa—Dyspepsia—Paclitaxel—lung cancer	0.000447	0.000553	CcSEcCtD
Carbidopa—Body temperature increased—Cisplatin—lung cancer	0.000447	0.000553	CcSEcCtD
Carbidopa—Asthenia—Irinotecan—lung cancer	0.000447	0.000552	CcSEcCtD
Carbidopa—Fatigue—Etoposide—lung cancer	0.000447	0.000552	CcSEcCtD
Carbidopa—Constipation—Etoposide—lung cancer	0.000443	0.000548	CcSEcCtD
Carbidopa—Pain—Etoposide—lung cancer	0.000443	0.000548	CcSEcCtD
Carbidopa—Decreased appetite—Paclitaxel—lung cancer	0.000442	0.000546	CcSEcCtD
Carbidopa—DDC—Metabolism—UGT1A1—lung cancer	0.00044	0.0023	CbGpPWpGaD
Carbidopa—Dry mouth—Docetaxel—lung cancer	0.000439	0.000543	CcSEcCtD
Carbidopa—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000439	0.000543	CcSEcCtD
Carbidopa—Haemoglobin—Methotrexate—lung cancer	0.000439	0.000543	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000439	0.000542	CcSEcCtD
Carbidopa—Fatigue—Paclitaxel—lung cancer	0.000438	0.000541	CcSEcCtD
Carbidopa—Haemorrhage—Methotrexate—lung cancer	0.000437	0.00054	CcSEcCtD
Carbidopa—Pollakiuria—Doxorubicin—lung cancer	0.000437	0.00054	CcSEcCtD
Carbidopa—Asthenia—Gemcitabine—lung cancer	0.000435	0.000538	CcSEcCtD
Carbidopa—Pain—Paclitaxel—lung cancer	0.000434	0.000537	CcSEcCtD
Carbidopa—Constipation—Paclitaxel—lung cancer	0.000434	0.000537	CcSEcCtD
Carbidopa—Confusional state—Docetaxel—lung cancer	0.000434	0.000537	CcSEcCtD
Carbidopa—Urinary tract disorder—Methotrexate—lung cancer	0.000431	0.000533	CcSEcCtD
Carbidopa—Oedema—Docetaxel—lung cancer	0.000431	0.000532	CcSEcCtD
Carbidopa—Weight increased—Doxorubicin—lung cancer	0.00043	0.000532	CcSEcCtD
Carbidopa—Pruritus—Gemcitabine—lung cancer	0.000429	0.000531	CcSEcCtD
Carbidopa—Urethral disorder—Methotrexate—lung cancer	0.000428	0.000529	CcSEcCtD
Carbidopa—Infection—Docetaxel—lung cancer	0.000428	0.000529	CcSEcCtD
Carbidopa—Weight decreased—Doxorubicin—lung cancer	0.000428	0.000529	CcSEcCtD
Carbidopa—Feeling abnormal—Etoposide—lung cancer	0.000427	0.000528	CcSEcCtD
Carbidopa—Diarrhoea—Irinotecan—lung cancer	0.000426	0.000527	CcSEcCtD
Carbidopa—DDC—Metabolism—GNG11—lung cancer	0.000424	0.00222	CbGpPWpGaD
Carbidopa—Gastrointestinal pain—Etoposide—lung cancer	0.000424	0.000524	CcSEcCtD
Carbidopa—Shock—Docetaxel—lung cancer	0.000424	0.000524	CcSEcCtD
Carbidopa—Thrombocytopenia—Docetaxel—lung cancer	0.000422	0.000521	CcSEcCtD
Carbidopa—Feeling abnormal—Paclitaxel—lung cancer	0.000419	0.000518	CcSEcCtD
Carbidopa—Hypersensitivity—Cisplatin—lung cancer	0.000417	0.000515	CcSEcCtD
Carbidopa—Gastrointestinal pain—Paclitaxel—lung cancer	0.000415	0.000514	CcSEcCtD
Carbidopa—Diarrhoea—Gemcitabine—lung cancer	0.000415	0.000513	CcSEcCtD
Carbidopa—Neuropathy peripheral—Doxorubicin—lung cancer	0.000413	0.000511	CcSEcCtD
Carbidopa—Dizziness—Irinotecan—lung cancer	0.000412	0.000509	CcSEcCtD
Carbidopa—Urticaria—Etoposide—lung cancer	0.000412	0.000509	CcSEcCtD
Carbidopa—Anorexia—Docetaxel—lung cancer	0.00041	0.000507	CcSEcCtD
Carbidopa—Body temperature increased—Etoposide—lung cancer	0.00041	0.000506	CcSEcCtD
Carbidopa—Abdominal pain—Etoposide—lung cancer	0.00041	0.000506	CcSEcCtD
Carbidopa—Urinary tract infection—Doxorubicin—lung cancer	0.00041	0.000506	CcSEcCtD
Carbidopa—Asthenia—Cisplatin—lung cancer	0.000406	0.000502	CcSEcCtD
Carbidopa—DDC—Metabolism—ALDOA—lung cancer	0.000404	0.00211	CbGpPWpGaD
Carbidopa—Urticaria—Paclitaxel—lung cancer	0.000404	0.000499	CcSEcCtD
Carbidopa—Hypotension—Docetaxel—lung cancer	0.000402	0.000497	CcSEcCtD
Carbidopa—Abdominal pain—Paclitaxel—lung cancer	0.000402	0.000496	CcSEcCtD
Carbidopa—Body temperature increased—Paclitaxel—lung cancer	0.000402	0.000496	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—TP53—lung cancer	0.0004	0.0021	CbGpPWpGaD
Carbidopa—Vomiting—Irinotecan—lung cancer	0.000396	0.00049	CcSEcCtD
Carbidopa—Agranulocytosis—Doxorubicin—lung cancer	0.000393	0.000486	CcSEcCtD
Carbidopa—Rash—Irinotecan—lung cancer	0.000393	0.000486	CcSEcCtD
Carbidopa—Dermatitis—Irinotecan—lung cancer	0.000392	0.000485	CcSEcCtD
Carbidopa—DDC—Metabolism—NCOA3—lung cancer	0.000392	0.00205	CbGpPWpGaD
Carbidopa—Headache—Irinotecan—lung cancer	0.00039	0.000482	CcSEcCtD
Carbidopa—Insomnia—Docetaxel—lung cancer	0.000389	0.000481	CcSEcCtD
Carbidopa—Diarrhoea—Cisplatin—lung cancer	0.000387	0.000478	CcSEcCtD
Carbidopa—Paraesthesia—Docetaxel—lung cancer	0.000387	0.000478	CcSEcCtD
Carbidopa—Alopecia—Methotrexate—lung cancer	0.000386	0.000477	CcSEcCtD
Carbidopa—Vomiting—Gemcitabine—lung cancer	0.000386	0.000477	CcSEcCtD
Carbidopa—Dyspnoea—Docetaxel—lung cancer	0.000384	0.000475	CcSEcCtD
Carbidopa—Somnolence—Docetaxel—lung cancer	0.000383	0.000473	CcSEcCtD
Carbidopa—Mental disorder—Methotrexate—lung cancer	0.000383	0.000473	CcSEcCtD
Carbidopa—Rash—Gemcitabine—lung cancer	0.000383	0.000473	CcSEcCtD
Carbidopa—Dermatitis—Gemcitabine—lung cancer	0.000382	0.000473	CcSEcCtD
Carbidopa—Hypersensitivity—Etoposide—lung cancer	0.000382	0.000472	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCG2—lung cancer	0.000382	0.002	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ADCY1—lung cancer	0.000382	0.002	CbGpPWpGaD
Carbidopa—Haemoglobin—Doxorubicin—lung cancer	0.00038	0.00047	CcSEcCtD
Carbidopa—Headache—Gemcitabine—lung cancer	0.00038	0.00047	CcSEcCtD
Carbidopa—Rhinitis—Doxorubicin—lung cancer	0.000379	0.000469	CcSEcCtD
Carbidopa—Dyspepsia—Docetaxel—lung cancer	0.000379	0.000469	CcSEcCtD
Carbidopa—Haemorrhage—Doxorubicin—lung cancer	0.000378	0.000468	CcSEcCtD
Carbidopa—Hypoaesthesia—Doxorubicin—lung cancer	0.000376	0.000465	CcSEcCtD
Carbidopa—Decreased appetite—Docetaxel—lung cancer	0.000374	0.000463	CcSEcCtD
Carbidopa—Hypersensitivity—Paclitaxel—lung cancer	0.000374	0.000463	CcSEcCtD
Carbidopa—DDC—Metabolism—HPGDS—lung cancer	0.000374	0.00196	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ENO2—lung cancer	0.000374	0.00196	CbGpPWpGaD
Carbidopa—Urinary tract disorder—Doxorubicin—lung cancer	0.000374	0.000462	CcSEcCtD
Carbidopa—Dysgeusia—Methotrexate—lung cancer	0.000372	0.00046	CcSEcCtD
Carbidopa—DDC—Metabolism—PPP2R1B—lung cancer	0.000372	0.00195	CbGpPWpGaD
Carbidopa—Gastrointestinal disorder—Docetaxel—lung cancer	0.000372	0.00046	CcSEcCtD
Carbidopa—Asthenia—Etoposide—lung cancer	0.000372	0.00046	CcSEcCtD
Carbidopa—Fatigue—Docetaxel—lung cancer	0.000371	0.000459	CcSEcCtD
Carbidopa—Urethral disorder—Doxorubicin—lung cancer	0.000371	0.000458	CcSEcCtD
Carbidopa—Nausea—Irinotecan—lung cancer	0.00037	0.000457	CcSEcCtD
Carbidopa—Pain—Docetaxel—lung cancer	0.000368	0.000455	CcSEcCtD
Carbidopa—Constipation—Docetaxel—lung cancer	0.000368	0.000455	CcSEcCtD
Carbidopa—Back pain—Methotrexate—lung cancer	0.000368	0.000455	CcSEcCtD
Carbidopa—Pruritus—Etoposide—lung cancer	0.000367	0.000453	CcSEcCtD
Carbidopa—DDC—Circadian rythm related genes—IL6—lung cancer	0.000367	0.00192	CbGpPWpGaD
Carbidopa—Asthenia—Paclitaxel—lung cancer	0.000364	0.000451	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTT1—lung cancer	0.000363	0.0019	CbGpPWpGaD
Carbidopa—Nausea—Gemcitabine—lung cancer	0.00036	0.000446	CcSEcCtD
Carbidopa—Vomiting—Cisplatin—lung cancer	0.00036	0.000445	CcSEcCtD
Carbidopa—Pruritus—Paclitaxel—lung cancer	0.000359	0.000444	CcSEcCtD
Carbidopa—DDC—Metabolism—GCLC—lung cancer	0.000359	0.00188	CbGpPWpGaD
Carbidopa—DDC—Metabolism—CYP2A6—lung cancer	0.000359	0.00188	CbGpPWpGaD
Carbidopa—Vision blurred—Methotrexate—lung cancer	0.000358	0.000443	CcSEcCtD
Carbidopa—Rash—Cisplatin—lung cancer	0.000357	0.000441	CcSEcCtD
Carbidopa—Dermatitis—Cisplatin—lung cancer	0.000356	0.00044	CcSEcCtD
Carbidopa—Feeling abnormal—Docetaxel—lung cancer	0.000355	0.000439	CcSEcCtD
Carbidopa—Diarrhoea—Etoposide—lung cancer	0.000355	0.000438	CcSEcCtD
Carbidopa—Ill-defined disorder—Methotrexate—lung cancer	0.000353	0.000436	CcSEcCtD
Carbidopa—Gastrointestinal pain—Docetaxel—lung cancer	0.000352	0.000435	CcSEcCtD
Carbidopa—Anaemia—Methotrexate—lung cancer	0.000351	0.000434	CcSEcCtD
Carbidopa—Flushing—Doxorubicin—lung cancer	0.000351	0.000434	CcSEcCtD
Carbidopa—Diarrhoea—Paclitaxel—lung cancer	0.000348	0.00043	CcSEcCtD
Carbidopa—Malaise—Methotrexate—lung cancer	0.000343	0.000424	CcSEcCtD
Carbidopa—Dizziness—Etoposide—lung cancer	0.000343	0.000424	CcSEcCtD
Carbidopa—Abdominal pain—Docetaxel—lung cancer	0.00034	0.000421	CcSEcCtD
Carbidopa—Body temperature increased—Docetaxel—lung cancer	0.00034	0.000421	CcSEcCtD
Carbidopa—Leukopenia—Methotrexate—lung cancer	0.00034	0.000421	CcSEcCtD
Carbidopa—DDC—Metabolism—ENO1—lung cancer	0.00034	0.00178	CbGpPWpGaD
Carbidopa—Dizziness—Paclitaxel—lung cancer	0.000336	0.000415	CcSEcCtD
Carbidopa—Nausea—Cisplatin—lung cancer	0.000336	0.000415	CcSEcCtD
Carbidopa—Alopecia—Doxorubicin—lung cancer	0.000334	0.000413	CcSEcCtD
Carbidopa—Cough—Methotrexate—lung cancer	0.000332	0.00041	CcSEcCtD
Carbidopa—Mental disorder—Doxorubicin—lung cancer	0.000331	0.00041	CcSEcCtD
Carbidopa—Convulsion—Methotrexate—lung cancer	0.000329	0.000407	CcSEcCtD
Carbidopa—Vomiting—Etoposide—lung cancer	0.000329	0.000407	CcSEcCtD
Carbidopa—Rash—Etoposide—lung cancer	0.000327	0.000404	CcSEcCtD
Carbidopa—Dermatitis—Etoposide—lung cancer	0.000326	0.000403	CcSEcCtD
Carbidopa—Headache—Etoposide—lung cancer	0.000325	0.000401	CcSEcCtD
Carbidopa—Flatulence—Doxorubicin—lung cancer	0.000324	0.000401	CcSEcCtD
Carbidopa—Chest pain—Methotrexate—lung cancer	0.000324	0.0004	CcSEcCtD
Carbidopa—Tension—Doxorubicin—lung cancer	0.000323	0.000399	CcSEcCtD
Carbidopa—Vomiting—Paclitaxel—lung cancer	0.000323	0.000399	CcSEcCtD
Carbidopa—Dysgeusia—Doxorubicin—lung cancer	0.000322	0.000399	CcSEcCtD
Carbidopa—Rash—Paclitaxel—lung cancer	0.00032	0.000396	CcSEcCtD
Carbidopa—Dermatitis—Paclitaxel—lung cancer	0.00032	0.000396	CcSEcCtD
Carbidopa—Discomfort—Methotrexate—lung cancer	0.00032	0.000395	CcSEcCtD
Carbidopa—Nervousness—Doxorubicin—lung cancer	0.00032	0.000395	CcSEcCtD
Carbidopa—Back pain—Doxorubicin—lung cancer	0.000319	0.000394	CcSEcCtD
Carbidopa—Headache—Paclitaxel—lung cancer	0.000318	0.000393	CcSEcCtD
Carbidopa—Hypersensitivity—Docetaxel—lung cancer	0.000317	0.000392	CcSEcCtD
Carbidopa—Muscle spasms—Doxorubicin—lung cancer	0.000317	0.000391	CcSEcCtD
Carbidopa—Confusional state—Methotrexate—lung cancer	0.000313	0.000387	CcSEcCtD
Carbidopa—Vision blurred—Doxorubicin—lung cancer	0.00031	0.000384	CcSEcCtD
Carbidopa—Asthenia—Docetaxel—lung cancer	0.000309	0.000382	CcSEcCtD
Carbidopa—Infection—Methotrexate—lung cancer	0.000308	0.000381	CcSEcCtD
Carbidopa—Nausea—Etoposide—lung cancer	0.000308	0.00038	CcSEcCtD
Carbidopa—Ill-defined disorder—Doxorubicin—lung cancer	0.000306	0.000378	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP2E1—lung cancer	0.000305	0.0016	CbGpPWpGaD
Carbidopa—Pruritus—Docetaxel—lung cancer	0.000305	0.000377	CcSEcCtD
Carbidopa—Anaemia—Doxorubicin—lung cancer	0.000304	0.000376	CcSEcCtD
Carbidopa—Thrombocytopenia—Methotrexate—lung cancer	0.000304	0.000376	CcSEcCtD
Carbidopa—Agitation—Doxorubicin—lung cancer	0.000303	0.000374	CcSEcCtD
Carbidopa—Nausea—Paclitaxel—lung cancer	0.000302	0.000373	CcSEcCtD
Carbidopa—DDC—Metabolism—NQO1—lung cancer	0.000302	0.00158	CbGpPWpGaD
Carbidopa—Hyperhidrosis—Methotrexate—lung cancer	0.0003	0.000371	CcSEcCtD
Carbidopa—Malaise—Doxorubicin—lung cancer	0.000297	0.000367	CcSEcCtD
Carbidopa—Anorexia—Methotrexate—lung cancer	0.000296	0.000366	CcSEcCtD
Carbidopa—Syncope—Doxorubicin—lung cancer	0.000295	0.000365	CcSEcCtD
Carbidopa—Leukopenia—Doxorubicin—lung cancer	0.000295	0.000364	CcSEcCtD
Carbidopa—Diarrhoea—Docetaxel—lung cancer	0.000295	0.000364	CcSEcCtD
Carbidopa—Palpitations—Doxorubicin—lung cancer	0.000291	0.00036	CcSEcCtD
Carbidopa—Hypotension—Methotrexate—lung cancer	0.00029	0.000358	CcSEcCtD
Carbidopa—Loss of consciousness—Doxorubicin—lung cancer	0.000289	0.000358	CcSEcCtD
Carbidopa—Cough—Doxorubicin—lung cancer	0.000287	0.000355	CcSEcCtD
Carbidopa—Convulsion—Doxorubicin—lung cancer	0.000285	0.000353	CcSEcCtD
Carbidopa—Dizziness—Docetaxel—lung cancer	0.000285	0.000352	CcSEcCtD
Carbidopa—Hypertension—Doxorubicin—lung cancer	0.000284	0.000351	CcSEcCtD
Carbidopa—Insomnia—Methotrexate—lung cancer	0.000281	0.000347	CcSEcCtD
Carbidopa—Chest pain—Doxorubicin—lung cancer	0.00028	0.000347	CcSEcCtD
Carbidopa—Anxiety—Doxorubicin—lung cancer	0.000279	0.000345	CcSEcCtD
Carbidopa—Paraesthesia—Methotrexate—lung cancer	0.000279	0.000345	CcSEcCtD
Carbidopa—Discomfort—Doxorubicin—lung cancer	0.000277	0.000342	CcSEcCtD
Carbidopa—Dyspnoea—Methotrexate—lung cancer	0.000277	0.000342	CcSEcCtD
Carbidopa—Somnolence—Methotrexate—lung cancer	0.000276	0.000341	CcSEcCtD
Carbidopa—Dry mouth—Doxorubicin—lung cancer	0.000274	0.000339	CcSEcCtD
Carbidopa—Vomiting—Docetaxel—lung cancer	0.000274	0.000338	CcSEcCtD
Carbidopa—Dyspepsia—Methotrexate—lung cancer	0.000273	0.000338	CcSEcCtD
Carbidopa—DDC—Metabolism—STK11—lung cancer	0.000272	0.00142	CbGpPWpGaD
Carbidopa—Rash—Docetaxel—lung cancer	0.000271	0.000336	CcSEcCtD
Carbidopa—Dermatitis—Docetaxel—lung cancer	0.000271	0.000335	CcSEcCtD
Carbidopa—Confusional state—Doxorubicin—lung cancer	0.000271	0.000335	CcSEcCtD
Carbidopa—Decreased appetite—Methotrexate—lung cancer	0.00027	0.000334	CcSEcCtD
Carbidopa—Headache—Docetaxel—lung cancer	0.00027	0.000333	CcSEcCtD
Carbidopa—Oedema—Doxorubicin—lung cancer	0.000269	0.000332	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Methotrexate—lung cancer	0.000268	0.000331	CcSEcCtD
Carbidopa—Fatigue—Methotrexate—lung cancer	0.000268	0.000331	CcSEcCtD
Carbidopa—Infection—Doxorubicin—lung cancer	0.000267	0.00033	CcSEcCtD
Carbidopa—Pain—Methotrexate—lung cancer	0.000265	0.000328	CcSEcCtD
Carbidopa—Shock—Doxorubicin—lung cancer	0.000264	0.000327	CcSEcCtD
Carbidopa—Thrombocytopenia—Doxorubicin—lung cancer	0.000263	0.000325	CcSEcCtD
Carbidopa—Hyperhidrosis—Doxorubicin—lung cancer	0.00026	0.000321	CcSEcCtD
Carbidopa—Anorexia—Doxorubicin—lung cancer	0.000256	0.000317	CcSEcCtD
Carbidopa—Nausea—Docetaxel—lung cancer	0.000256	0.000316	CcSEcCtD
Carbidopa—Feeling abnormal—Methotrexate—lung cancer	0.000256	0.000316	CcSEcCtD
Carbidopa—Gastrointestinal pain—Methotrexate—lung cancer	0.000254	0.000314	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTP1—lung cancer	0.000252	0.00132	CbGpPWpGaD
Carbidopa—Hypotension—Doxorubicin—lung cancer	0.000251	0.00031	CcSEcCtD
Carbidopa—Urticaria—Methotrexate—lung cancer	0.000247	0.000305	CcSEcCtD
Carbidopa—Abdominal pain—Methotrexate—lung cancer	0.000245	0.000303	CcSEcCtD
Carbidopa—Body temperature increased—Methotrexate—lung cancer	0.000245	0.000303	CcSEcCtD
Carbidopa—DDC—Metabolism—CAT—lung cancer	0.000245	0.00128	CbGpPWpGaD
Carbidopa—Insomnia—Doxorubicin—lung cancer	0.000243	0.0003	CcSEcCtD
Carbidopa—Paraesthesia—Doxorubicin—lung cancer	0.000241	0.000298	CcSEcCtD
Carbidopa—Dyspnoea—Doxorubicin—lung cancer	0.00024	0.000296	CcSEcCtD
Carbidopa—Somnolence—Doxorubicin—lung cancer	0.000239	0.000295	CcSEcCtD
Carbidopa—DDC—Metabolism—ABCB1—lung cancer	0.000238	0.00125	CbGpPWpGaD
Carbidopa—Dyspepsia—Doxorubicin—lung cancer	0.000237	0.000292	CcSEcCtD
Carbidopa—DDC—Metabolism—TYMS—lung cancer	0.000234	0.00122	CbGpPWpGaD
Carbidopa—Decreased appetite—Doxorubicin—lung cancer	0.000234	0.000289	CcSEcCtD
Carbidopa—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000232	0.000287	CcSEcCtD
Carbidopa—Fatigue—Doxorubicin—lung cancer	0.000232	0.000286	CcSEcCtD
Carbidopa—DDC—Metabolism—GSTM1—lung cancer	0.000231	0.00121	CbGpPWpGaD
Carbidopa—Pain—Doxorubicin—lung cancer	0.00023	0.000284	CcSEcCtD
Carbidopa—Constipation—Doxorubicin—lung cancer	0.00023	0.000284	CcSEcCtD
Carbidopa—Hypersensitivity—Methotrexate—lung cancer	0.000229	0.000283	CcSEcCtD
Carbidopa—Asthenia—Methotrexate—lung cancer	0.000223	0.000275	CcSEcCtD
Carbidopa—Feeling abnormal—Doxorubicin—lung cancer	0.000221	0.000274	CcSEcCtD
Carbidopa—Gastrointestinal pain—Doxorubicin—lung cancer	0.00022	0.000272	CcSEcCtD
Carbidopa—Pruritus—Methotrexate—lung cancer	0.00022	0.000271	CcSEcCtD
Carbidopa—DDC—Metabolism—CYP1A1—lung cancer	0.000219	0.00115	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ERCC2—lung cancer	0.000217	0.00114	CbGpPWpGaD
Carbidopa—Urticaria—Doxorubicin—lung cancer	0.000213	0.000264	CcSEcCtD
Carbidopa—Body temperature increased—Doxorubicin—lung cancer	0.000212	0.000263	CcSEcCtD
Carbidopa—Abdominal pain—Doxorubicin—lung cancer	0.000212	0.000263	CcSEcCtD
Carbidopa—Diarrhoea—Methotrexate—lung cancer	0.000212	0.000262	CcSEcCtD
Carbidopa—Dizziness—Methotrexate—lung cancer	0.000205	0.000254	CcSEcCtD
Carbidopa—Hypersensitivity—Doxorubicin—lung cancer	0.000198	0.000245	CcSEcCtD
Carbidopa—Vomiting—Methotrexate—lung cancer	0.000197	0.000244	CcSEcCtD
Carbidopa—Rash—Methotrexate—lung cancer	0.000196	0.000242	CcSEcCtD
Carbidopa—Dermatitis—Methotrexate—lung cancer	0.000196	0.000242	CcSEcCtD
Carbidopa—Headache—Methotrexate—lung cancer	0.000194	0.00024	CcSEcCtD
Carbidopa—Asthenia—Doxorubicin—lung cancer	0.000193	0.000238	CcSEcCtD
Carbidopa—Pruritus—Doxorubicin—lung cancer	0.00019	0.000235	CcSEcCtD
Carbidopa—DDC—Metabolism—APOA1—lung cancer	0.000188	0.000984	CbGpPWpGaD
Carbidopa—Nausea—Methotrexate—lung cancer	0.000184	0.000228	CcSEcCtD
Carbidopa—Diarrhoea—Doxorubicin—lung cancer	0.000184	0.000227	CcSEcCtD
Carbidopa—Dizziness—Doxorubicin—lung cancer	0.000178	0.00022	CcSEcCtD
Carbidopa—DDC—Metabolism—PIK3CG—lung cancer	0.000172	0.000898	CbGpPWpGaD
Carbidopa—Vomiting—Doxorubicin—lung cancer	0.000171	0.000211	CcSEcCtD
Carbidopa—Rash—Doxorubicin—lung cancer	0.000169	0.000209	CcSEcCtD
Carbidopa—Dermatitis—Doxorubicin—lung cancer	0.000169	0.000209	CcSEcCtD
Carbidopa—Headache—Doxorubicin—lung cancer	0.000168	0.000208	CcSEcCtD
Carbidopa—DDC—Metabolism—POMC—lung cancer	0.000163	0.000855	CbGpPWpGaD
Carbidopa—Nausea—Doxorubicin—lung cancer	0.00016	0.000197	CcSEcCtD
Carbidopa—DDC—Metabolism—CREBBP—lung cancer	0.000159	0.000833	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CD—lung cancer	0.000151	0.00079	CbGpPWpGaD
Carbidopa—DDC—Metabolism—ALB—lung cancer	0.000149	0.00078	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CB—lung cancer	0.000132	0.000688	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTGS2—lung cancer	0.00013	0.000682	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PTEN—lung cancer	0.000114	0.000595	CbGpPWpGaD
Carbidopa—DDC—Metabolism—EP300—lung cancer	0.000108	0.000567	CbGpPWpGaD
Carbidopa—DDC—Metabolism—PIK3CA—lung cancer	8.02e-05	0.00042	CbGpPWpGaD
Carbidopa—DDC—Metabolism—AKT1—lung cancer	6.55e-05	0.000343	CbGpPWpGaD
